| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-05 | BlackRock Inc. | Seres Therapeutics, Inc. | 6,825,399 | 4.5% | EDGAR |
| SC 13G/A | 2024-02-12 | JANUS HENDERSON GROUP PLC | Seres Therapeutics, Inc. | 483 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Seres Therapeutics, Inc. | 19,388,579 | 15.0% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | Seres Therapeutics, Inc. | 7,339,454 | 5.7% | EDGAR |
| SC 13G/A | 2023-11-07 | FEDERATED HERMES, INC. | Seres Therapeutics, Inc. | 5,175,805 | 4.0% | EDGAR |
| SC 13G/A | 2023-05-10 | FEDERATED HERMES, INC. | Seres Therapeutics, Inc. | 11,500,520 | 9.0% | EDGAR |
| SC 13G/A | 2023-04-06 | BlackRock Inc. | Seres Therapeutics, Inc. | 6,249,086 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-10 | JANUS HENDERSON GROUP PLC | Seres Therapeutics, Inc. | 11,248,292 | 9.0% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Seres Therapeutics, Inc. | 18,688,761 | 15.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Seres Therapeutics, Inc. | 6,092,937 | 4.9% | EDGAR |
| SC 13G/A | 2023-02-03 | STATE STREET CORP | Seres Therapeutics, Inc. | - | 3.7% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | Seres Therapeutics, Inc. | 6,458,974 | 5.2% | EDGAR |
| SC 13G/A | 2023-02-01 | FEDERATED HERMES, INC. | Seres Therapeutics, Inc. | 18,085,938 | 14.5% | EDGAR |
| SC 13G/A | 2022-08-09 | BlackRock Inc. | Seres Therapeutics, Inc. | 5,874,358 | 4.7% | EDGAR |
| SC 13D/A | 2022-07-22 | Nestle Health Science US Holdings, Inc. | Seres Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-07-11 | FEDERATED HERMES, INC. | Seres Therapeutics, Inc. | 17,982,256 | 14.5% | EDGAR |
| SC 13D/A | 2022-07-07 | Flagship VentureLabs IV, LLC | Seres Therapeutics, Inc. | 2,734,994 | 2.2% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | Seres Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Nikko Asset Management Americas, Inc. | Seres Therapeutics, Inc. | 785,519 | 0.9% | EDGAR |
| SC 13G | 2022-02-14 | FEDERATED HERMES, INC. | Seres Therapeutics, Inc. | 6,914,136 | 7.5% | EDGAR |